Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Clinical trial NCT01409161 · RECRUITING
Trial details
- NCT number
- NCT01409161
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-05
- Primary completion
- 2027-12-18
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.